Home › Tricuspid Valve Insufficiency › Michigan
Tricuspid Valve Insufficiency clinical trials in Michigan
4 studies for Tricuspid Valve Insufficiency are looking for participants at sites in Michigan.
VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
- Henry Ford Hospital, Detriot
Recruiting
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07516444Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
- Ascension St. John, Detroit
Recruiting
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT06212193The TRICURE EFS Study
- University of Michigan Hospital and Health Systems, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06506942Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
Recruiting
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04097145From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.